Menu

Srinivasa Rao (Paid)

138 posts

Posts (138)

Srinivasa Rao (Paid) ENDP 7 years ago #134

Opportunity to average down. Good price. EBITA attractive. Opioid issue will not impact ENDP. Settlements will happen soon. Pipeline strong. Hold long. ~98% is still Institutional holding.

Srinivasa Rao (Paid) ENDP 7 years ago #137

Okla.'s $572M Win In J&J Opioid Fight On Shaky Ground
A first-of-its-kind court decision blaming Johnson & Johnson for rampant painkiller abuse in Oklahoma rests on fragile legal conclusions that seem vulnerable to appeal and could fail to influence judges in other high-stakes opioid cases, experts say.